scispace - formally typeset
S

Suzhen Wang

Researcher at University of Texas MD Anderson Cancer Center

Publications -  7
Citations -  841

Suzhen Wang is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Medicine & Immune system. The author has an hindex of 1, co-authored 1 publications receiving 652 citations.

Papers
More filters
Journal ArticleDOI

Novel Molecular Determinants of Response or Resistance to Immune Checkpoint Inhibitor Therapies in Melanoma

TL;DR: Several novel SMGs and re-annotated mutational signatures that are linked to immunotherapy response or resistance and an immune subtype was found to exhibit favorable prognoses, and further studies are required to validate these findings.
Journal ArticleDOI

Favorable immune checkpoint inhibitor outcome of patients with melanoma and NSCLC harboring FAT1 mutations

TL;DR: Wang et al. as discussed by the authors investigated the association of atypical cadherin 1 (FAT1) mutations with ICI response and outcome and found that patients with FAT1 mutations had a significantly improved survival outcome than those wild-type patients.
Journal ArticleDOI

HSPG2 Mutation Association with Immune Checkpoint Inhibitor Outcome in Melanoma and Non-Small Cell Lung Cancer

TL;DR: It is uncovered that HSPG2 mutations were predictive of a better ICI response and associated with preferable immunogenicity, which may be considered as a genomic determinant to customize biotherapy strategies.
Journal ArticleDOI

Bioinformatic analysis identifies the immunological profile of turner syndrome with different X chromosome origins

TL;DR: In this paper , the authors investigated the immunological characteristics of Turner syndrome (TS) patients with different X-chromosomal origins and found that the most enriched signals were immune response-related.